About: http://data.cimple.eu/news-article/40e5ab59b3c27294ee5d9caac1ed04429fd4703b8dd0b646479b1430

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: http://data.cimple.eu/news-article/40e5ab59b3c27294ee5d9caac1ed04429fd4703b8dd0b646479b1430 Goto Sponge Distinct Permalink

An Entity of Type : schema:NewsArticle, within Data Space : data.cimple.eu associated with source document(s)

Attributes	Values
rdf:type	schema:NewsArticle
schema:articleBody	Swiss pharmaceutical giant Roche announced Friday it had received emergency approval from US regulators for a new and much faster test for diagnosing the deadly new coronavirus. The US Food and Drug Administration (FDA) has given the green light to commercialise the SARS-CoV-2 Test to detect the virus that has sparked the global COVID-19 pandemic, Roche said in a statement. The test can be run in high volumes on fully automated equipment, Roche said, suggesting it could provide more results far faster than other tests available. "We are increasing the speed definitely by a factor of 10," Thomas Schinecker, head of Roche's diagnostics unit, said in an interview with Bloomberg News. Widespread testing is essential in the race to rein in the spread of the virus, which has so far infected more than 130,000 people and killed nearly 5,000 worldwide. The new Roche tests, which will also now be available in markets that accept the European CE-mark certification, are run on Roche's widely available cobas 6800/8800 systems and can provide results within 3.5 hours, the company said. In a 24-hour period, the largest machines can provide results on up to 4,128 tests, it said. "It is important to quickly and reliably detect whether a patient is infected" with the virus," Schinecker said in the statement, insisting that speeding up the process of providing reliable diagnostics was "crucial to combat this serious disease." Roche said it would have millions of tests available each month, and that it was committed to pushing the limits of its production capacity and delivering as many tests as possible. noo-nl/jh
schema:headline	US regulators approve Roche's new and faster COVID-19 test
schema:mentions	Thomas Wayne Rein Bloomberg News Hoffmann-La Roche Medication Switzerland Test cricket Food and Drug Administration Pandemic Virus Severe acute respiratory syndrome coronavirus 2 CE marking
schema:author	http://data.cimple.eu/organization/1f0054d541e000623a2c1e561a247c073ef6328e8be9ffafda7b3fcd
schema:datePublished	2020-03-13 (xsd:date)
http://data.cimple...sPoliticalLeaning	other political leaning
http://data.cimple...logy#hasSentiment	positive sentiment
http://data.cimple...readability_score	83 (xsd:integer)
http://data.cimple...tology#hasEmotion	happiness

Faceted Search & Find service v1.16.115 as of Oct 09 2023

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3238 as of Jul 16 2024, on Linux (x86_64-pc-linux-musl), Single-Server Edition (126 GB total memory, 11 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software